The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.50
Bid: 88.00
Ask: 95.00
Change: 0.00 (0.00%)
Spread: 7.00 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 91.50
UAV Live PriceLast checked at -
Unicorn AIM VCT is an Investment Trust

To provide shareholders with an attractive return from a diversified portfolio, predominantly invested in the shares of AIM quoted companies by maintaining dividend distributions to shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Voluntary Interim Management Statement

14 Jan 2019 13:28

RNS Number : 0389N
Unicorn AIM VCT PLC
14 January 2019
 

Unicorn AIM VCT plc ("the Company")

Interim Management Statement 

For the period from 1 October 2018 to 31 December 2018

 

Introduction

This voluntary Interim Management Statement (IMS) covers the three month period ended 31 December 2018, together with relevant information up to the date of publication. 

 

Investment Objective

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% (80% for accounting periods commencing after 5 April 2019) of the Company's total assets are to be invested in qualifying investments of which 70% by VCT value (30% in respect of investments made before 6 April 2018 from funds raised before 6 April 2011) must be in ordinary shares which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance

The period under review has been an extremely challenging one for UK equity markets. Uncertainty surrounding the outcome of Brexit negotiations, an escalating trade war between the US and China, concerns over a slowdown in the Chinese economy and deteriorating financial results from some of the world's most highly valued quoted companies, led to a rapid reversal in investor sentiment. In the UK, a combination of weak consumer spending, over-supply in the retail sector and a number of high profile corporate insolvencies exacerbated the sharp sell-off in equities. The short term health of the UK economy appears dependent on securing a successful deal with the European Union, which, in itself, now seems in doubt.

 

In the past three months, the largest declines in value have generally been experienced by smaller quoted companies. In total return terms, since the start of October 2018, the FTSE AIM All-Share Index has fallen by 21.5%, while the Numis Smaller Companies Index (including AIM) has declined by 14.6%. The FTSE 250 Index fell by 13.3% over the same period, while the FTSE 100 Index declined by 9.6%.

 

Your Company has not been immune from the wider market turmoil. Although performance in the period was not specifically impacted by profit warnings from any of our investee companies, the value of the portfolio as a whole nonetheless experienced a meaningful decline.

 

In the three month period ended 31 December 2018, Net Asset Value fell from 171.8 pence per share at the start of the period to 141.7 pence per share as at 31 December 2018, a decline of 17.5%. Of the 79 VCT qualifying investments held in the portfolio, the majority recorded share price declines during the period under review. Of these, eight investments generated unrealised capital losses in excess of £1 million each. The performance of the non-qualifying investments was similarly impacted by the general malaise in equity markets during the period under review.

 

At 31 December 2018, an estimated 80.5% of total assets were invested in VCT qualifying companies.

 

Material Transactions

During the period under review, six VCT qualifying investments were made at a total cost of nearly £3 million. Of these investments, two were in businesses new to the portfolio, while four were in the form of follow-on funding.

In aggregate, almost £2.5 million was raised from the partial disposal of a number of holdings during the period. The purpose of such disposals is threefold; to ensure stock specific risk is contained, to lock in capital profits for future distribution to Shareholders via dividend payments and to help manage liquidity requirements. Two further investments; Communisis and Sinclair Pharma, were acquired by trade buyers during the period realising total proceeds of £2.3 million and a capital gain on investment of £0.5m. A holding in Science Group was also fully realised, raising £1.0 million and crystallising a capital gain of £0.8m.

Top Ten VCT Qualifying Holdings as at 31 December 2018

Stock

% of fund

Abcam

8.6

Tracsis

5.9

Mattioli Woods

3.9

Hasgrove

3.9

Interactive Investor

3.8

Anpario

3.7

City Pub Group

3.5

MaxCyte

3.1

Cohort

2.7

Tristel

2.4

Total

41.5%

 

Share Buy-Backs

During the period from 1 October 2018 to 31 December 2018, the Company bought back 407,205 of its own Ordinary Shares for cancellation, at an average price of 129.6 pence per share including costs. As at 31 December 2018, there were 116,818,843 Ordinary Shares in issue.

 

 

 

 

Dividends

The Board has recommended a final dividend of 3.5 pence per share for the financial year ended 30 September 2018. The proposed dividend was approved by Shareholders at the Company's Annual General Meeting, which was held on 10 January 2019, and will be paid on 1 February 2019 to Shareholders on the register on 11 January 2019. Total dividends paid in respect of the financial year ended 30 September 2018, will therefore amount to 6.5 pence per share (2017: 6.5 pence per share).

 

Material Events

On 20 December 2018, the Directors announced that they intend to launch an offer for subscription to raise £15 million (with an over-allotment facility to raise up to a further £10 million) through the issue of new ordinary shares ("the Offer"). The prospectus, which will contain the full details and terms and conditions of the Offer, is expected to be available at the end of January 2019.

 

There were no other material events during the period from 1 October 2018 to 31 December 2018.

 

We remain confident that we have a well diversified portfolio of interesting companies of varying maturities. While stock markets may well remain volatile in the short term, we are cautiously optimistic that, once the outcome of the Brexit negotiations becomes clear, the portfolio performance should become more positive.

 

Chris Hutchinson

Unicorn Asset Management

Investment Manager

 

14 January 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZMGMMFDKGLZM
Date   Source Headline
13th Feb 20234:53 pmRNSTransaction in Own Shares
7th Feb 20236:14 pmRNSResult of AGM
6th Feb 20235:30 pmRNSOffer for Subscription Update
6th Feb 202312:02 pmRNSOffer for Subscription – Update
6th Feb 20237:00 amRNSNet Asset Value(s)
1st Feb 202310:34 amRNSTotal Voting Rights
30th Jan 202311:24 amRNSInterim Management Statement
24th Jan 202312:09 pmRNSOffer for Subscription and Issue of Prospectus
16th Jan 20239:51 amRNSTransaction in Own Shares
6th Jan 20233:06 pmRNSNet Asset Value(s)
14th Dec 20227:00 amRNSFinal Results
8th Dec 202210:12 amRNSIntention to Launch an Offer
5th Dec 20222:43 pmRNSNet Asset Value(s)
4th Nov 20225:47 pmRNSNet Asset Value(s)
21st Oct 20221:38 pmRNSNet Asset Value(s)
3rd Oct 202212:45 pmRNSTotal Voting Rights
20th Sep 20226:19 pmRNSTransaction in Own Shares
5th Sep 202212:32 pmRNSNet Asset Value(s)
11th Aug 202211:27 amRNSIssue of Equity
4th Aug 20222:47 pmRNSNet Asset Value(s)
26th Jul 202211:30 amRNSInterim Management Statement
7th Jul 20229:50 amRNSNet Asset Value(s)
1st Jul 202210:00 amRNSTotal Voting Rights
22nd Jun 20225:44 pmRNSTransaction in Own Shares
14th Jun 20223:27 pmRNSNet Asset Value(s)
10th Jun 20227:00 amRNSHalf-year Report
24th May 20222:26 pmRNSDirectorate Change
6th May 202212:33 pmRNSNet Asset Value(s)
11th Apr 20229:02 amRNSNet Asset Value(s) Replacement
7th Apr 20223:14 pmRNSNet Asset Value(s)
1st Apr 202210:43 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTransaction in Own Shares
4th Mar 20221:40 pmRNSDirector/PDMR Shareholding
4th Mar 202212:44 pmRNSTotal Voting Rights
4th Mar 202212:39 pmRNSIssue of Equity
2nd Mar 20222:26 pmRNSNet Asset Value(s)
1st Mar 20229:58 amRNSTotal Voting Rights
18th Feb 20221:27 pmRNSInterim Management Statement
15th Feb 20224:51 pmRNSTransaction in Own Shares
10th Feb 20227:00 amRNSIssue of Equity
9th Feb 202212:11 pmRNSOffer for Subscription - Update
7th Feb 202210:12 amRNSNet Asset Value(s)
3rd Feb 20221:34 pmRNSResult of AGM
1st Feb 202211:52 amRNSTotal Voting Rights
24th Jan 202210:17 amRNSOffer for Subscription and Issue of Prospectus
17th Jan 202212:44 pmRNSTransaction in Own Shares
6th Jan 20222:49 pmRNSNet Asset Value(s)
4th Jan 20229:41 amRNSTotal Voting Rights
20th Dec 20215:30 pmRNSTransaction in Own Shares
16th Dec 202112:33 pmRNSConfirmation of Dividends

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.